BioNTech SE

Yahoo Finance • last month

Notable healthcare headlines for the week: CVS, Eli Lilly and Novartis in focus

Wall Street's major averages ended lower on Friday, with the S&P 500 (SP500 [https://seekingalpha.com/symbol/SP500]) and the Nasdaq (COMP:IND [https://seekingalpha.com/symbol/COMP:IND]) ending the week in the red as the AI trade came under... Full story

Yahoo Finance • last month

How Recent Developments Are Rewriting The BioNTech Investment Story

BioNTech's latest narrative update reflects a slightly higher fair value estimate of about $138, tempered by a modestly increased discount rate of roughly 6.72%, as analysts balance confidence in the COVID-19 franchise with more cautious l... Full story

Yahoo Finance • last month

Moderna (MRNA) Q2 2025 Earnings Call Transcript

Image source: The Motley Fool. DATE Friday, Aug. 1, 2025 at 8 a.m. ET CALL PARTICIPANTS Chief Executive Officer — Stéphane BancelChief Financial Officer — James MockPresident — Stephen Hoge TAKEAWAYS Revenue -- $142 million total, wi... Full story

Yahoo Finance • last month

China Leads Therapeutic Access with 74 Approved Immuno-Oncology Agents

Dublin, Dec. 10, 2025 (GLOBE NEWSWIRE) -- The "Strategic Intelligence: Immuno-oncology (2025)" has been added to ResearchAndMarkets.com's offering. The latest report delves into the dynamic field of immuno-oncology, shedding light on c... Full story

Yahoo Finance • last month

BioNTech and Bristol Myers Squibb Present First Global Phase 2 Data for PD-L1xVEGF-A Bispecific Antibody Pumitamig Showing Encouraging Efficacy in Advanced Triple-Negative Breast Cancer

BioNTech SE Global interim Phase 2 data in locally advanced/metastatic triple-negative breast cancer (”TNBC”) show encouraging antitumor activity for investigational therapy pumitamig (BNT327/BMS986545) plus chemotherapy in first- and sec... Full story

Yahoo Finance • last month

European Equities Traded in the US as ADRs Little Changed in Monday Trading

European equities traded in the US as American depositary receipts were little changed late Monday m PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • last month

BioNTech and OncoC4 Announce Clinically Meaningful Overall Survival Benefit for Selective Treg Modulator Gotistobart in Patients with Previously Treated Squamous Non-Small Cell Lung Cancer

Selective Treg modulator gotistobart (BNT316/ONC-392) showed a reduction in the risk of death by more than half compared to standard of care chemotherapy and a manageable safety profile in the first of two stages of the global Phase 3 tria... Full story

Yahoo Finance • last month

BioNTechs und OncoC4s selektiver Treg-Modulatorkandidat Gotistobart erzielte klinisch relevanten Gesamtüberlebensvorteil bei Patientinnen und Patienten mit zuvor behandeltem Plattenepithelkarzinom der Lunge

Der selektive Treg-Modulatorkandidat Gotistobart (BNT316/ONC-392) zeigte eine Verringerung des Sterberisikos um mehr als die Hälfte im Vergleich zur Standard-Chemotherapie sowie ein kontrollierbares Sicherheitsprofil im ersten von zwei Abs... Full story

Yahoo Finance • last month

BioNTech Achieves Minimum Condition in CureVac Exchange Offer

The minimum condition for the offer has been satisfied, with 184,071,410 shares of CureVac, representing approximately 81.74% of CureVac’s issued and outstanding shares, tendered prior to the expiration of the initial offering periodThe su... Full story

Yahoo Finance • last month

BioNTech erfüllt Mindestannahmebedingungen im Rahmen des Umtauschangebots für CureVac-Aktien

Mindestannahmebedingung für das Angebot wurde erfüllt; es wurden vor Ablauf der ursprünglichen Angebotsfrist insgesamt 184.071.410 CureVac-Aktien angedient, was etwa 81,74 % der ausgegebenen und im Umlauf befindlichen CureVac-Aktien entspr... Full story

Yahoo Finance • last month

Moderna Slammed By 'Fear, Confusion' After FDA Alleges Covid Shots Killed 10

Moderna and other vaccine stocks tumbled Monday after an FDA director reportedly issued a memo that says Covid shots killed 10 children. Continue Reading View Comments... Full story

Yahoo Finance • last month

Nvidia's Synopsys investment, Disney stock pops on Zootopia 2

Yahoo Finance host Julie Hyman kicks off Yahoo Finance's Market Minute with some of the top stories of Monday's trading session, including Nvidia's (NVDA) investment in Synopsys (SNPS), Disney's (DIS) "Zootopia 2," and vaccine stock moves.... Full story

Yahoo Finance • last month

2 Top Dividend Stocks to Buy and Hold

Key Points Bristol Myers Squibb and Johnson & Johnson have had a tough past few years due to several factors. Both companies are looking to right the ship thanks to new product launches. These healthcare leaders routinely increase their... Full story

Yahoo Finance • 2 months ago

BioNTech’s exchange offer for German mRNA vaccine peer CureVac set to expire Dec. 3

[Mature female virologist examining test tube while working in laboratory] Maskot * BioNTech SE (BNTX [https://seekingalpha.com/symbol/BNTX]) on Wednesday announced [https://seekingalpha.com/pr/20320982-biontech-shares-progress-on-excha... Full story

Yahoo Finance • 2 months ago

BioNTech Shares Progress on Exchange Offer for CureVac Shares and Highlights December 3, 2025, at 9:00 a.m. Eastern Time Expiration

Offer set to expire at 9:00 am Eastern Time on December 3, 2025, with CureVac shareholders advised to tender their shares by 6:00 pm Eastern Time on December 2, 2025, due to operational deadlines.Exchange ratio of 0.05363 of a BioNTech Ame... Full story

Yahoo Finance • 2 months ago

BioNTech informiert über Fortschritte im Rahmen des Umtauschangebots für CureVac-Aktien und weist auf Ablauf des Angebots am 3. Dezember 2025 um 15 Uhr MEZ hin

Ablauf des Angebots am 3. Dezember 2025 um 15 Uhr MEZ (9:00 Uhr EST); CureVac-Aktionärinnen und -Aktionären wird empfohlen, ihre Aktien aufgrund operativer Fristen bis spätestens 3. Dezember 2025, 0:00 Uhr MEZ (2. Dezember 2025 um 18:00 Uh... Full story

Yahoo Finance • 2 months ago

Top Healthcare revenue stocks as hedge funds sell Tech stocks to buy the sector

[3D charts graph with gift box, coin, analysis business financial data, online marketing isolated on pink background. business strategy minimal concept, 3d render illustration] warat42/iStock via Getty Images Goldman Sachs’ Tony Pasquarie... Full story

Yahoo Finance • 2 months ago

Stocks making the biggest moves midday: Walt Disney, Sweetgreen, Cisco, Planet Fitness and more

Check out the companies making headlines in midday trading: Planet Fitness — The gym chain jumped about 4% after it issued guidance for the fiscal years 2026 through 2028. Planet Fitness expects new club unit growth to range between 6% and... Full story

Yahoo Finance • 2 months ago

4 stocks to watch on Thursday: DIS, RIO, JD, BNTX

SementsovaLesia Stock index futures fell on Thursday after President Donald Trump signed a federal spending bill into law, officially ending the government shutdown following its passage in Congress. Here are four stocks to watch on the d... Full story

Yahoo Finance • 2 months ago

Pfizer is said to divest remaining stake in BioNTech

[Pfizer Canada head office in Kirkland, Quebec, Canada.] JHVEPhoto/iStock Editorial via Getty Images BioNTech (BNTX [https://seekingalpha.com/symbol/BNTX]) ADRs lost ~5% in the premarket on Thursday after Bloomberg News reported that Pfiz... Full story